Table 1.
Intended and unintended damage after neurotoxic lesions of the amygdala
| Subjects | Intended Damage
|
Unintended Damage
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amygdala
|
Hippocampus
|
Entorhinal
|
||||||||||
| Rt% | Lt% | X% | W% | Rt% | Lt% | X% | W% | Rt% | Lt% | X% | W% | |
| Neo-A-F1 | 82.3 | 0.0 | 41.2 | 0.0 | 0.0 | 00 | 0.0 | 0.0 | 18.3 | 0.0 | 9.2 | 0.0 |
| Neo-A-F3 | 100 | 32.2 | 66.1 | 32.2 | 2.5 | 0.0 | 1.2 | 0.0 | 21.8 | 2.9 | 12.4 | 0.6 |
| Neo-A-F4 | 90.9 | 89.3 | 90.1 | 81.1 | 1.9 | 0.0 | 1.0 | 0.0 | 12.3 | 0.0 | 6.2 | 0.0 |
| Neo-A-F5 | 61.6 | 58.4 | 60.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.0 | 0.8 | 0.0 |
| Neo-A-F6 | 100 | 97.7 | 98.8 | 97.7 | 2.4 | 7.9 | 5.1 | 0.2 | 1.3 | 2.0 | 1.6 | 0.03 |
| Neo-A-F7 | 98.3 | 99.0 | 98.6 | 97.3 | 4.3 | 2.1 | 3.2 | 0.1 | 7.3 | 2.5 | 4.9 | 0.2 |
| Mean | 88.9 | 62.8 | 75.8 | 57.4 | 1.9 | 1.7 | 1.8 | 0.05 | 10.4 | 1.2 | 5.9 | 0.18 |
|
| ||||||||||||
| Neo-A-M1 | 100 | 80.6 | 90.3 | 80.6 | 8.9 | 9.0 | 9.0 | 0.8 | 8.3 | 15.8 | 12.0 | 1.3 |
| Neo-A-M3 | 70.3 | 90.8 | 80.6 | 63.9 | 3.1 | 5.3 | 4.2 | 0.2 | 2.1 | 31.4 | 16.8 | 0.7 |
| Neo-A-M4 | 50.5 | 84.9 | 67.7 | 42.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Neo-A-M6 | 77.3 | 92.3 | 84.8 | 71.3 | 4.4 | 0.0 | 2.2 | 0.0 | 0.0 | 0.3 | 0.2 | 0.0 |
| Neo-A-M7 | 90.9 | 98.9 | 94.9 | 90.0 | 5.1 | 0.6 | 2.9 | 0.03 | 1.4 | 0.0 | 0.7 | 0.0 |
| Neo-A-M8 | 100 | 87.0 | 93.5 | 87.0 | 6.4 | 0.4 | 3.4 | 0.03 | 7.1 | 0.0 | 3.6 | 0.0 |
| Neo-A-M9 | 61.8 | 93.2 | 77.5 | 57.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.4 | 0.0 |
| Mean | 78.7 | 89.7 | 84.2 | 70.5 | 4.0 | 2.2 | 3.1 | 0.15 | 2.7 | 6.9 | 4.8 | 0.3 |
L%; percent damage in the left hemisphere; R%; percent damage in the right hemisphere; X%; average damage to both hemispheres; W%; weighted average damage to both hemispheres(W%=L%×R%)/100), Neo-A-F: female amygdala lesion subject, Neo-A-M: male amygdala lesion subject.